Clinical Research Directory
Browse clinical research sites, groups, and studies.
Probiotics for Diaper Dermatitis
Sponsor: University Maribor
Summary
The goal of this randomized controlled clinical trial is to determine the effect of the probiotic OMNiBiOTiC® Panda in treating diaper dermatitis in children under the age of two years. The main question it aims to answer is: Is the probiotic OMNiBiOTiC® Panda effective in reducing the duration of diaper dermatitis in children under the age of two years? Researchers will compare the probiotic and placebo group to see if the duration of diaper dermatitis is significant among the two groups. Participants will: * receive 6 droplets daily of probiotic or placebo for 3 weeks and * observe and record improvement of diaper rash symptoms each day using a diary.
Official title: PROBIOTICS FOR TREATING DIAPER DERMATITIS IN CHILDREN - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED CLINICAL TRIAL
Key Details
Gender
All
Age Range
1 Month - 2 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2025-08-14
Completion Date
2026-03-01
Last Updated
2025-11-24
Healthy Volunteers
No
Conditions
Interventions
OMNiBiOTiC® Panda
Multistrain Probiotic OMNiBiOTiC® Panda containing: Bifidobacterium bifidum W23 Bifidobacterium lactis W51 Bifidobacterium lactis W52 Lactococcus lactis W58 and sunflower oil
Placebo
Placebo containing sunflower oil and maltodextrin
Locations (1)
University of Maribor, Faculty of Health Sciences
Maribor, Slovenia